pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

7,922 catalysts · 4,876 phase readout · 2,367 8k filing · 286 earnings · 275 pdufa · 138 phase 2 completion · 64 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 0 catalysts2026-07-23: 0 catalysts2026-07-24: 0 catalysts2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout4,876
  • 8k filing2,367
  • earnings286
  • pdufa275
  • phase 2 completion138
  • phase 1 completion64
  • phase 1 initiation39
  • phase 2 initiation35
  • phase 1 2 completion29
  • phase 0 trial completion22
  • therapy area
    • Oncology122
    • Infectious Disease36
    • Cardiology33
    • Immunology25
    • Dermatology21
    • Pulmonology16
    • Ophthalmology12
    • Women's Health11
    • Pain10

    Date TBD

    50
    ›RECRUITINGphase readoutNCT05597124: Exercise to Improve Brain Health in Older African Americans

    Sponsor: Rutgers, The State University of New Jersey. Phase: PHASE2. Conditions: Aging, Alzheimer Disease, Healthy Aging, Cognitive Change

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07353723: Nimotuzumab Combined With Toripalimab and Chemotherapy for Locally Advanced Tonsillar Cancer

    Sponsor: Tang-Du Hospital. Phase: PHASE2. Conditions: Head & Neck Cancer

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07118124: Pediatric Adhesion and New Dermal Approach Study

    Sponsor: iRhythm Technologies, Inc.. Phase: NA. Conditions: Syncope, Pediatric, Congenital Athymia, Congenital Heart Disease, Arrhythmia, Arrhythmia in Children

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT00250159: Natural History Study of Patients With Excess Androgen

    Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). Phase: . Conditions: Congenital Adrenal Hyperplasia (CAH), Familial Male-Limited Precocious Puberty (FMPP)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04661280: Donepezil Versus Non-drug Treatment in Alzheimer's Disease.

    Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: PHASE3. Conditions: Alzheimer Disease, Early Onset

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT06972979: Investigation of a Patient Support Intervention for Statin Medication Adherence

    Sponsor: Ascension Health. Phase: NA. Conditions: Medication Adherence

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07512596: Study on the Safety and Efficacy of Polymyxin E2 Methanesulfonate for Injection in the Treatment of Hospital-Acquired Bacterial Pneumonia/Ventilator-Associated Bacterial Pneumonia Caused by Carbapenem-Resistant Gram-Negative Bacteria

    Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Phase: PHASE2. Conditions: Hospital-acquired Bacterial Pneumonia/Ventilator-associated Bacterial Pneumonia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07232862: Analysis Of The Effect Of A Fine Manual Skills Intervention In A Specific Context On The Linguistic Processing of Healthy Young Adults

    Sponsor: Federal University of Health Science of Porto Alegre. Phase: NA. Conditions: Healthy Participants

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05396846: My Best GI Eating Study

    Sponsor: University of Michigan. Phase: NA. Conditions: Colorectal Neoplasms

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07418827: Determinants and Consequences of the Transition to Adulthood for Adolescents With Severe Haemophilia: TRANSHEMO 2, an Ancillary Study to the TRANSHEMO Project

    Sponsor: Assistance Publique Hopitaux De Marseille. Phase: . Conditions: Haemophilia

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05703269: Comparing Single vs Multiple Dose Radiation for Cancer Patients With Brain Metastasis and Receiving Immunotherapy

    Sponsor: Wake Forest University Health Sciences. Phase: NA. Conditions: NSCLC, Renal Cell Carcinoma, Breast Carcinoma, Melanoma, Brain Metastases, Adult, Non-small Cell Lung Cancer, SCLC, Small-cell Lung Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03218969: Treatment of Restless Leg Syndrome (RLS) Augmentation With Ecopipam, a D1 Specific Antagonist

    Sponsor: William Ondo, MD. Phase: PHASE1. Conditions: Restless Legs Syndrome, Augmentation

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05226169: Efficacy and Safety oF FErric CarboxymalTose in Patients With Advanced Gastric Cancer(EFFECT-AGC)

    Sponsor: Asan Medical Center. Phase: PHASE3. Conditions: Advanced Gastric Carcinoma

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04762069: A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme

    Sponsor: CNS Pharmaceuticals, Inc.. Phase: PHASE2. Conditions: Glioblastoma Multiforme, Adult

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02064569: Safety Evaluation of Gene Therapy in Leber Hereditary Optic Neuropathy (LHON) Patients

    Sponsor: GenSight Biologics. Phase: PHASE1. Conditions: Leber Hereditary Optic Neuropathy

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT01413269: Randomized Study of Hypofractionated and Conventional Fractionation Radiotherapy After Breast Conservative Surgery

    Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Phase: PHASE3. Conditions: Breast Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02784769: Matrix Aging and Aneurysm

    Sponsor: CHU de Reims. Phase: NA. Conditions: Aortic Aneurysm

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06994169: Glofitamab in Real Life

    Sponsor: The Lymphoma Academic Research Organisation. Phase: . Conditions: Large B-cell Lymphoma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07516041: Metaverse- and VR-Supported Education in a Digital Breastfeeding Museum: Long-Term Effects on Breastfeeding Process, Self-Efficacy, and Motivation

    Sponsor: Uludag University. Phase: NA. Conditions: Metaverse, Virtual Reality, Digital Museum, Breastfeeding Education, Breastfeeding Self-Efficacy, Breastfeeding Duration, Breastfeeding Motivation, Breastfeeding Problems Assessment

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03507205: Korean Nationwide Multicenter Pooled Registry of Drug-Eluting Stents

    Sponsor: Seoul National University Hospital. Phase: . Conditions: Coronary Artery Disease

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07470905: Development and Preclinical Validation of DiaBuddy, a Point-of-Care Decision Support Tool for Children With Type 1 Diabetes: A Pilot Clinical Study

    Sponsor: Regency Hospital Kanpur. Phase: NA. Conditions: Type 1 Diabetes (T1D)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT02954094: A Longitudinal Observational Study of the Natural History and Management of Patients With HCC

    Sponsor: Target PharmaSolutions, Inc.. Phase: . Conditions: Hepatocellular Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06189066: Long COVID Ultrasound Trial

    Sponsor: SecondWave Systems Inc.. Phase: NA. Conditions: Long Covid

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07137429: Platelet Volunteers, Longitudinal and Multi-omic Study

    Sponsor: National Heart, Lung, and Blood Institute (NHLBI). Phase: . Conditions: Thrombosis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07091929: A Research Study to Evaluate the Safety and Preliminary Efficacy of SGC001 in Patients With Myocardial Infarction

    Sponsor: Beijing Sungen Biomedical Technology Co., Ltd. Phase: PHASE1. Conditions: Anterior Myocardial Infarction

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06850831: Effect of Intracoronary N-Acetylcysteine in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

    Sponsor: dr. Ahmad Yasa, Sp.JP, Subsp.K.I.(K), M.Kes, FIHA, FasCC, FA. Phase: PHASE2. Conditions: STEMI - ST Elevation Myocardial Infarction (MI), Primary PCI - STEMI

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07548931: Cold Plasma and Early Microbial Colonization of Healing Abutments

    Sponsor: Kahramanmaras Sutcu Imam University. Phase: NA. Conditions: Tooth Loss

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07370402: The Analgesic Efficacy and Safety of Flurbiprofen Patch in Patients With Herpes Zoster

    Sponsor: Beijing Tiantan Hospital. Phase: NA. Conditions: Herpes Zoster, Pain

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07456553: Impacted Tooth With Immediate Implant Placement

    Sponsor: University of Bari Aldo Moro. Phase: NA. Conditions: Impacted Tooth

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07400653: A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D)

    Sponsor: Pfizer. Phase: PHASE3. Conditions: Obesity, Overweight and/or Obesity, Overweight, Diabetes, Type 2, Type 2 Diabetes

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07057037: Phase 3 Study of the Efficacy and Safety of MR Arthrography Using the NEMO-103 Injection in Patients With Known or Suspected Shoulder Joint Diseases

    Sponsor: Inventera Inc.. Phase: PHASE3. Conditions: Rotator Cuff Tear, Labral Tear, Rotator Cuff Tendinosis, Rotator Cuff Tendonitis, Articular Cartilage Injury, Glenohumeral Ligament, Long Head Biceps Tendon Tear, Adhesive Capsulitis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06166537: GRACE: Evaluating Compression Stockings in Patients That Require Extended Duration Pharmacological Thromboprophylaxis

    Sponsor: Imperial College London. Phase: NA. Conditions: Venous Thromboembolism, Surgery

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT03816345: Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

    Sponsor: National Cancer Institute (NCI). Phase: PHASE1. Conditions: Autoimmune Disease, Crohn Disease, Dermatomyositis, Hematopoietic and Lymphoid Cell Neoplasm, Inflammatory Bowel Disease, Malignant Solid Neoplasm, Multiple Sclerosis, Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis, Sjogren Syndrome, Systemic Lupus Erythematosus, Systemic Scleroderma, Ulcerative Colitis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06563895: Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

    Sponsor: Eidos Therapeutics, a BridgeBio company. Phase: PHASE3. Conditions: Amyloidosis, Amyloid Cardiomyopathy, Transthyretin Amyloidosis, Cardiomyopathies, Heart Diseases, Polyneuropathies

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07320677: Finding Heart Failure in Those Prescribed Loop Diuretics in Primary Care in Jersey

    Sponsor: Government of Jersey. Phase: NA. Conditions: Heart Failure, Diuretics

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07523412: Dimensional Changes of Peri-implant Tissues Following Jumping Gap Grafting Using Erythropoietin Gel Mixed With Xenograft.

    Sponsor: Ain Shams University. Phase: PHASE4. Conditions: Peri-implant Bone and Soft Tissues

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07323381: Effects of Henagliflozin Proline and Metformin XR on Body Composition in Geriatric Patients With Newly Diagnosed T2DM

    Sponsor: Bin Lu. Phase: PHASE4. Conditions: Diabetes Type 2

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07533981: ¹²⁹Xe(XENON) MRI Program

    Sponsor: Alexei Ouriadov. Phase: NA. Conditions: Healthy Volunteers - Male and Female

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT02598219: Evaluation of Sentinel Node Policy in Early Stage Endometrial Carcinomas at Intermediate and High Risk of Recurrence.

    Sponsor: Centre Oscar Lambret. Phase: PHASE3. Conditions: Non Endometrioid Carcinoma, Endometrioid Carcinoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04702581: A Randomized Trial of Delayed Radiotherapy in Patients Low-grade Oligodendrogliomas Requiring a Treatment Other Than Surgery

    Sponsor: Hospices Civils de Lyon. Phase: PHASE3. Conditions: Oligodendroglioma, Low-grade Oligodendroglioma, 1p19q Codeletion

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT05036681: A Phase II Study of Futibatinib and Pembrolizumab in Metastatic Microsatellite Stable Endometrial Carcinoma

    Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Metastatic Cancer, Endometrium Cancer, Endometrial Carcinoma

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07475819: Posture Exercises and Ergonomics Education

    Sponsor: Bahçeşehir University. Phase: NA. Conditions: Work Related Musculoskeletal Disorders, Ergonomic Risk Exposure, Postural Disorders

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03358719: DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, Decitabine, and Nivolumab in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia

    Sponsor: Roswell Park Cancer Institute. Phase: PHASE1. Conditions: Acute Myeloid Leukemia, Blasts 30 Percent or Less of Bone Marrow Nucleated Cells, Chronic Myelomonocytic Leukemia, High Risk Myelodysplastic Syndrome, Myelodysplastic Syndrome, Refractory Anemia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05966519: ROSA Knee Intraoperative Planning Flexibility Study

    Sponsor: Zimmer Biomet. Phase: . Conditions: Osteo Arthritis Knee, Rheumatoid Arthritis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04648930: Special Drug Use Observational Study of Xolair in Patients With Severe to Most Severe Seasonal Allergic Rhinitis Aged ≥ 12 Years and < 18 Years Whose Symptoms Were Inadequately Controlled Despite to Conventional Therapies

    Sponsor: Novartis Pharmaceuticals. Phase: . Conditions: Allergic Rhinitis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05185128: Neural Basis of Social Cognition Deficits

    Sponsor: Loma Linda University. Phase: NA. Conditions: Autism Spectrum Disorder, Psychosis, Social Communication

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT03439865: Ivacaftor for Acquired CFTR Dysfunction in Chronic Rhinosinusitis

    Sponsor: University of Alabama at Birmingham. Phase: EARLY_PHASE1. Conditions: Chronic Rhinosinusitis (Diagnosis)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07389967: Nutrition Awareness Among Women With Non-Metastatic Breast Cancer

    Sponsor: UNC Lineberger Comprehensive Cancer Center. Phase: NA. Conditions: Breast Cancer, Breast Cancer Metastatic

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07487467: Autologous SVF Therapy for Type 2 Diabetes

    Sponsor: Kaiser Clinic and Hospital. Phase: NA. Conditions: Diabetes Mellitus, Type 2

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06630000: Focused Acceptance and Commitment Therapy (FACT)

    Sponsor: Children's Mercy Hospital Kansas City. Phase: NA. Conditions: Pediatric Feeding Disorders

    full page →ctgov ↗
    ← prev
    page 64 of 159
    next →